Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Controlled Trial on Use of Letrozole in the Medical Management of Tubal Ectopic Pregnancies

NCT04341545 is registered in ClinicalTrials.gov with Queen Mary Hospital, Hong Kong as lead sponsor.

NCT NCT04341545
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04341545 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Controlled Trial on Use of Letrozole in the Medical Management of Tubal Ectopic Pregnancies
Lead sponsor
Queen Mary Hospital, Hong Kong
Phase
Phase 3
Overall status
Unknown status
Start date
December 1, 2020
Completion date
March 31, 2025
Enrollment
214 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

tubal pregnancy